The Global Mass Spectrometer Market is likely to expand at a CAGR of 7.8% between 2019 and 2026. Fortune Business Insights in a report, titled “MASS SPECTROMETER: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2019-2026” predicts that the adoption of mass spectrometer equipment is likely to increase as this equipment can precisely measure the molecular weight of an analyst. The mass spectrometer instrument together with chromatography calculates the analytical mass of a particular molecule. The report predicts the Global Mass Spectrometer Market was valued at US$ 5,512.2 Mn in the year 2018 and is anticipated to reach US$ 10,044.7 Mn by 2026.

Browse Complete Report Details@ https://www.fortunebusinessinsights.com/industry-reports/mass-spectrometer-market-101068

Joel Launches a Novel Mass Spectrometer System to Expand its Product Line

• Shimadzu Corporation
• PerkinElmer Inc.
• WATERS
• Thermo Fisher Scientific Inc.
• Bruker
• AB Sciex
• Agilent Technology
• LECO
• JEOL USA
• Advion, Inc.

Key Industry Developments

• In June 2018, Thermo Scientific launched Orbitrap ID-X in collaboration with HighChem for characterization of small molecules.
• In April 2019, Agilent launched 6546 quadrupole time-of-flight LC/MS system, a hybrid mass spectrometer to deliver high resolution analytical data.
• In March 2019, JEOL USA announced the launch of GC-triple quadrupole mass spectrometer system to expand the company’s product line in mass spectrometer.

Get PDF Brochure of this Report@ https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/mass-spectrometer-market-101068

Market in North America Continues to Lead Owing to Presence of Key Players in the U.S.

Among regions, the market in North America is expected to maintain its dominance through the forecast period. Moreover, the regional market was valued at US$ 2,126.7 Mn in the year 2018. Presence of recognized key players and technological advancements are creating lucrative opportunities for the market. Governments in this region are granting funds to research institutes working on in mass spectrometry, which will further increase the mass spectrometer market share in North America. The University of Georgia recently received grants from the National Institutes of Health in the U.S. This funding is for conducting biomedical research and this is another factor responsible for the high growth of the market in this region. A report by the Industrial Research Institute (IRI) finds that the U.S. is the only country in the world who spends aggressively on research and development activities. Governments in North America are increasingly investing in areas such as biomedical, biotechnology, and proteomics. Such factors are likely to accelerate the mass spectrometer market size in North America. 

Following North America, the market in Europe is expected to grow considerably owing to increasing spending on research initiatives.

The mass spectrometer market in Asia Pacific is poised to surge owing to better economic conditions. This, coupled with the rising number of pharmaceutical companies, is expected to fuel demand for mass spectrometer analysis. Enabled by these factors, the mass spectrometer market is likely to witness higher CAGR in Asia Pacific in the forecast period.

The Global Intravenous Immunoglobulins Market to gain from rapid technological advancements taking place in the market. Recently Fortune Business Insights has published a report, titled Intravenous Immunoglobulins Market Size, Share and Global Trend By Indication (Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Guillain-Barré Syndrome (GBS), Immune Thrombocytopenic Purpura (ITP), Multifocal Motor Neuropathy (MMN)), Form (Liquid, Lyophilized), End User (Hospitals, Clinics, Homecare) & Geography Forecast till 2025

Browse Complete Report Details@ https://www.fortunebusinessinsights.com/industry-reports/intravenous-immunoglobulins-market-100593

Top Key Players Covered:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the global Intravenous Immunoglobulins market. Some of the companies operating the global Intravenous Immunoglobulins market are;

• CSL Behring
• Grifols, S.A.
• Kedrion S.p.A
• Octapharma
• Bio Products Laboratory Ltd.
• Biotest AG
• China Biologic Products Holdings, Inc.
• LFB SA and Shanghai RAAS Blood Products Co., Ltd.

Rapid adoption of digitalization among practitioners and patients is likely to fuel the demand in the global Intravenous Immunoglobulins market. Additionally, increasing per capita income and rising living standards is expected to drive the global Intravenous Immunoglobulins market during the forecast period 2018-2025.

However, high cost associated with the devices and lack of skilled professional to operate the system are a few factors that may hamper the growth in the global Intravenous Immunoglobulins market.

As stated in the report North America holds a significant share in the market. The trend is unlikely to change and North America may continue holding its position. The growth witnessed is attributable to high presence of key developers in nations such as Canada and U.S. 

The Asia Pacific Intravenous Immunoglobulins market is expected to expand at a promising CAGR during the forecast period. The constantly improving healthcare infrastructure in the region is expected to contribute to Asia Pacific market expansion.

Get PDF Brochure of this Report@ https://www.fortunebusinessinsights.com/enquiry/sample/intravenous-immunoglobulins-market-100593

Increasing Adoption of Immunoglobulins to Help Asia Pacific Register Fastest Growth

According to the report, The Global Intravenous Immunoglobulin Market was dominated by North America with a market value of US$ 5,587.4 Mn in 2017. The region is likley to remain dominant through the forecast period as well due to the presence of first line treatment for critical immune disorders. Other factors boosting the market in the region are rising number of patients and efficient results of the intravenous immunoglobulin treatment.

On the other side, the market in Asia Pacific is anticipated to grpow at faster rate in the coming years on account of the rise in awareness about the treatment option avaiulable for immunologic deficiencies. In addition to this, the rise in adoption and expenditure of immunoglobulins in economies such as Japan, China,and Indiais anticipated to boost the market in the region.

TABLE OF CONTENT:

1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

2. Executive Summary
3. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

4. Key Insights

4.1. Pipeline Analysis

4.2. Overview of Regulatory Scenario by Key Regions

4.3. Key Industry Developments

4.4. Number (Estimated) of Primary Immunodeficiency (PI) Patients byKey Countries

4.5. Overview of Reimbursement Scenario

The global examination lights market size is set to reach USD 259.6 million by 2026, exhibiting a CAGR of 3.5% during the forecast period. Increasing patient burden on healthcare facilities worldwide will act as the central growth driver for this market in the upcoming decade. The incidence of various kinds of diseases and disorders is rising at a rapid rate around the world. For instance, close to 463 million people were diabetic in 2019, according to the International Diabetes Federation (IDF). By 2045, IDF expects this number to reach 700 million. Similarly, the World Health Organization states that 18.1 million new cancer cases were reported in 2018 and the diseases caused 9.6 million deaths in the same year. Widespread prevalence of these chronic and life-threatening diseases has compelled governments across the globe to increase their healthcare spending. As a result, healthcare infrastructures globally are getting more robust and technologically advanced, making this factor one of the leading examination lights market trends.

For more information in the analysis of this report, visit:

https://www.fortunebusinessinsights.com/industry-reports/examination-lights-market-101944

Leading Players Covered in the Examination Lights Market Report:

• Mach GmbH & Co. KG
• Technomed India
• Steris plc.
• Stryker
• Skytron LLC
• SIMEON Medical GmbH & Co. KG
• Brandon Medical
• Hill-Rom Services Inc.

Fortune Business Insights™, through its report, titled “Examination Lights Market Size, Share & Industry Analysis, By Technology (LED, and Halogen), By End User (Hospitals, Clinics, and Others) and Regional Forecast, 2019-2026”, states that the value of this market stood at USD 197.1 million in 2018. Besides this, the report also provides the following information:

Profiles of the major players in the market;

• Noteworthy industry developments;
• Analysis of the different market segments;
• Research into the market trends, drivers, and restraints; and
• Evaluation of the current and future prospects in the market in general and in regions in particular.

Request a Sample Copy of Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/examination-lights-market-101944

 North America to Occupy the Driver’s Seat; Asia-Pacific to Grow at a Considerable CAGR

With a market size of USD 63.8 million in 2018, North America is poised to dominate the examination lights market share in the forecast period. The main forces driving the growth of this market include increasing focus on early diagnosis of diseases, high prevalence of chronic disorders such as obesity, and active adoption of advanced healthcare technologies in the region.

Asia-Pacific is anticipated to display a healthy CAGR on account of improving healthcare infrastructure in India and China coupled with entry of private players in the health sector. In Latin America and the Middle East & Africa, the market will be fueled by the rising government expenditure in developing healthcare infrastructure. 

The global anticoagulants market size is projected to reach 45.50 billion by the end of 2026. According to a report published by Fortune Business Insights, titled “Anticoagulants Market Size, Share & Industry Analysis, By Disease Indication (Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), Atrial Fibrillation, Heart Attacks, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026,” the market was worth USD 21.45 billion in 2018 and will exhibit a CAGR of 9.9% during the forecast period,2019-2026.

For more information in the analysis of this report, visit:https://www.fortunebusinessinsights.com/industry-reports/anticoagulants-market-101807

Some of the leading companies that are operating in the global market are:

• Bristol-Myers Squibb Company
• Pfizer Inc.
• Bayer AG
• Janssen Pharmaceuticals, Inc.
• Eisai Co., Ltd.
• Other Prominent Players

Request a Sample Copy of the Global Anticoagulants Market Research Report:https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/anticoagulants-market-101807

Anticoagulants are widely used across the healthcare industry for the treatment of several cardiovascular and health-related disorders. They are effectively used to treat blood clots avoid blockage of blood flow that is caused due to these drugs. The demand for anticoagulants has risen dramatically in recent years, owing to its exceptional properties. Anticoagulants are included in major drugs that are prescribed for the treatment of cardiovascular diseases. The properties of anticoagulants have led to a high product adoption in diverse industries. The increasing emphasis on the severe effects of unattended cardiovascular diseases will fuel the demand for anticoagulants.

The report offers insights into the latest anticoagulants market trends. It highlights leading companies in the market and discusses the strategies that these companies have adopted in recent years. The competitive landscape scenario has been discussed in detail. Additionally, the report encompasses several factors that have contributed to the growth of the market in recent years. Forecast values of the market have been provided for the period of 2019-2026. The market has been segmented on the basis of several criteria including route of administration, distribution type, and disease indication. Factual figures have been evaluated through trusted sources. Other forecast valued have been gathered through interviews and opinions of experienced market research professionals

Key Industry Developments:

February 2019: Novartis AG and Blackstone’s Life Sciences announced the launch of Anthos Therapeutics, a product aimed at the development of new and pipeline drugs that are comprised of anticoagulants.

October 2019: Janssen Pharmaceuticals received approval from the US Food and Drug Administration for usage of Riveraxoban, a drug aimed at the treatment of thromboembolic complications.

The global contraceptive pills market size is projected to reach USD 20.55 billion by 2026, exhibiting a CAGR of 5.8% during the forecast period. High degree of unfulfilled contraceptive needs in rural areas in emerging economies is expected to be one of the key drivers for the growth of this market. Data gathered under the Demographic and Health Surveys (DHS) conducted between 2005 and 2014 in 52 developing countries revealed that around 8% to 38% of married rural women, aged between 15 and 49 years, faced unmet contraceptive needs. The main reason for this gap is the lack of accessibility and local availability of birth-control pills in these areas. To counter this, governments in many developing and underdeveloped countries are taking efforts to make these modern day medications more accessible and affordable to the rural populace. This will effectively accelerate the oral contraceptives market growth during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contraceptive-pills-market-101802

Top Players Identified in the Contraceptive Pills Market Report by Fortune Business Insights™:

• Janssen Pharmaceutical Company
• Piramal Enterprises
• Allergan, plc
• Mylan N.V.
• Pfizer, Inc.
• Bayer AG
• Teva Pharmaceutical Industries
• HLL Lifecare Limited
• Merck & Co., Inc.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/contraceptive-pills-market-101802

Expeditious Need to Curb Population Growth to Feed Market Development

According to the United Nations’ Department of Economic and Social Affairs, by 2030, world population will reach 8.6 billion and by 2050, it will be 9.8 billion. The prevalent anxiety is that such explosion of numbers will create wide socio-economic imbalances, especially in poor countries. Proactive measures are being taken by governments across the globe about family planning and use of the contraceptives to avoid unnecessary pregnancies. This desperate need to control population growth is expected to be one of the leading contraceptive pills market trends in the immediate future. Furthermore, increasing prevalence of teenage pregnancies, particularly in the U.S. has also emerged as a central factor driving the growth of this market.

Increasing Popularity of Advanced Contraceptives to Propel the Market in North America

North America is slated to dominate the contraceptive pills market share, since the region generated USD 4.09 billion in revenue in 2018. The primary reason for this is the rising uptake of short-acting reversible contraceptives in the U.S. and patient-friendly reimbursement policies for oral birth-control pills. Europe will emerge as the second leading region in this market, led by France which has the highest birth rate in the region. Better reimbursement policies will also bode well for the market in Europe. Asia-Pacific will record the fastest growth owing to rising number of awareness drives conducted by the government and NGOs. In Latin America, the Middle East, and Africa, increasing presence of big pharmaceutical companies and growing literacy rates will drive the market in these regions.  

The global contact lenses market size is projected to reach USD 12.05 billion by 2026, exhibiting a CAGR of 4.8% during the forecast period. However, the market was worth USD 8.35 billion in 2018. This information is published in a recent report by Fortune Business Insights, titled, “Contact Lenses Market Size, Share & Industry Analysis, By Modality (Reusable and Disposable), By Design (Toric, Multi-Focal, and Spherical), By Distribution Channel (Retail Stores, Online Stores, and Ophthalmologists), and Regional Forecast, 2019-2026.” As per the report, rising per capita healthcare expenditure and increasing incidence of astigmatism and myopia are expected to affect the market positively.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contact-lenses-market-101775

Fortune Business Insights lists out some of the renowned companies operating in the contact lenses market. They are as follows:

• Contamac
• CooperVision
• HOYA Corporation
• Essilor
• Bausch & Lomb Incorporated
• Johnson & Johnson Vision Care, Inc. (Johnson & Johnson Services, Inc.)
• ZEISS International
• Alcon Vision LLC
• Other key market players

Request a Sample Copy of the Global Contact Lenses Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/contact-lenses-market-101775

Rising Prevalence of Ocular Disorders to Augment Market Growth

The World Health Organization (WHO) stated that approximately 1.7 million people are affected by presbyopia and around 153 million people reside with uncorrected refractive errors around the world. A rising prevalence of presbyopia worldwide is one of the main factors propeling the contact lenses market growth in the coming years. Also, many people are affected by ocular disorders, which in turn, is expected to boost growth of the market.

Spherical Segment to Dominate the Market Backed by High Prescriptions

In terms of design, the market is segregated into spherical, multifocal, and toric. Out of these, the spherical segment had generated 65.8% contact lenses market share in 2018 and was in the leading position. It occurred because these lenses are highly recommended by doctors for correcting ocular disorders. The toric segment, on the other hand, is anticipated to showcase considerable growth owing to its possession of numerous advantages, such as greater lens-to-lens reproducibility, easier fitting protocol, and better stabilization design. Lastly, the multifocal segment would expand at faster pace in the near future due to growing awareness and increasing new product launches.

Bausch & Lomb Unveils Ultra Multifocal for Astigmatism Contact Lenses

June 2019: Bausch & Lomb Incorporated, an eye health products company, headquartered in New York, announced the launch of its Bausch + Lomb Ultra contact lenses. It is a multifocal lens for astigmatism. The new silicon hydrogel lens was initially created for those affected by both presbyopia and astigmatism. It blends the company’s stability of OpticAlign toric design with its unique 3-Zone Progressive multifocal design to offer professionals and patients an innovative technology.

The global vaccines market size is expected to be USD 93.08 billion by 2026, exhibiting a CAGR of 10.7% during the forecast period. The growing prevalence of malaria around the world is a key factor boosting the vaccines market. According to the World Health Organization, in 2017, there were an estimated 219 million cases of malaria in 87 countries. Total funding for malaria control and elimination reached an estimated US$ 3.1 billion in 2017. Contributions from governments of endemic countries amounted to US$ 900 million, representing 28% of total funding. Furthermore, the increasing number of deaths caused by malaria has impelled government and pharmaceutical companies to develop advanced vaccines. According to the latest world malaria report, released in November 2018, there were 219 million cases of malaria in 2017, up from 217 million cases in 2016. The estimated number of malaria death stood at 435 000 in 2017, a similar number to the previous year.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/vaccines-market-101769

Some of the prominent companies in theVaccines Market are:

• GlaxoSmithKline plc.
• Sanofi
• Pfizer Inc.
• Merck & Co., Inc.
• Novartis AG
• Emergent BioSolutions, Inc.
• CSL Limited
• Inovio Pharmaceuticals, Inc.
• Bavarian Nordic
• Mitsubishi Tanabe Pharma Corporation.
• Other Prominent Players

According to the report, published by Fortune Business Insights in a report, titled “Vaccines Market Size, Share & Industry Analysis, By Type (Recombinant/Conjugate/Subunit, Inactivated, Live Attenuated and Toxoid), By Route of Administration (Parenteral and Oral), By Disease Indication (Viral Diseases and Bacterial Diseases), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Region Forecast, 2019-2026” the market size stood at USD 41.61 billion in 2018.

The report offers profound insights into all the prevailing trends of the vaccine market. It delivers an all-encompassing synopsis of all the segments and provides analytical statistics for the same. It is put together after extensive research followed by deep analysis to benefit companies, stakeholders, financers and potential investors. It is designed with an aim to provide a clear picture of the market size. In addition, it also includes the latest advancement and development, product launches, acquisitions, collaborations & partnerships, and others.

Request a Sample Copy of the Global Vaccines Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/vaccines-market-101769

Immunization Coverage Policies to Back Progression

One of the key drivers for the vaccine market growth is the increasing supply of vaccines around the world. The unmet needs and immunization policies for eradicating endemic diseases will further boost the vaccines market share. Furthermore, increasing efforts of pharmaceutical companies, government foundations, international organizations, and hospitals for providing cost-effective and free vaccines will aid in the vaccines market growth. Government surveillance in all the countries has become active in ensuring that every individual is vaccinated by recommended vaccines at a minimum cost or no cost. In addition, increasing R&D investment will create growth opportunities for the market in the forthcoming year.

The global microfluidic devices market is expected to gain impetus from increasing technological advancements in the biotechnology domain. According to a report by Fortune Business Insights, titled, “Microfluidic Devices Market Size, Share & Industry Analysis, By Device Type (Chips, Sensors, and Others), By Material (Glass, Silicon, PDMS and Others), By Applications (Pharmaceutical & Life Science Research, Diagnosis & Treatment, and Others), By End-user (Diagnostic Centers, Research Institutes, Pharmaceutical and Biotechnology Companies, Healthcare Facilities and Others) and Regional Forecast, 2019-2026,” the market is projected to reach USD 22.65 Billion by 2026, thereby exhibiting a CAGR of 20.5% during the forecast period. However, the global microfluidic devices market size was valued at USD 5.14 Billion in 2018. The report further states that renowned market players are focusing on low-cost materials for manufacturing microfluidic sensors and chips. It would contribute to the market growth in the forthcoming years.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/microfluidic-devices-market-101098

Fortune Business Insights profiles some of the renowned companies operating in the global microfluidic devices market. They are as follows:

• uFluidix
• Perkin Elmer
• Fluidigm
• Blacktrace Holdings Ltd. (Dolomite Microfluidic)
• Micronit
• BioFluidix GmbH‎
• Fluigent
• ALine, Inc.
• Philips
• Other prominent players

Get PDF Brochure of this Report@ https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/microfluidic-devices-market-101098

Schott AG Acquires MINIFAB to Develop Top-quality Polymer and Glass Solutions

Schott AG, a company specializing in the production of glass and glass-ceramics, based in Germany, declared that it has completed its acquisition of MINIFAB PTY Ltd., a provider of custom-designed and manufactured microfluidic and medical devices, based in Australia in June 2019. This strategic collaboration will enable both companies to upgrade their portfolios in the diagnostics market. They will be able to provide the products to their existing consumers as well as serve new consumers effectively in the upcoming years by developing centers of excellence for glass in Germany and polymer in Australia. MINIFAB is an expert in business development. The combination of Schott’s technology expertise and glass development with MINIFAB’s unique polymer technology will allow consumers to choose from a wide range of products for their specific applications. Overall, key market players are focusing on innovative product launches and strategic acquirements to gain competitive edge and increase microfluidic devices market share in the coming years.

Rising Usage of Microfluidic Devices to Boost Growth of Pharmaceutical and Biotechnology Companies Segment

In terms of end-user, the global microfluidic devices market is grouped into pharmaceutical and biotechnology companies, research institutes, diagnostic centers, and healthcare facilities and others. Out of these, the pharmaceutical and biotechnology companies segment is projected to lead the global market by acquiring the highest revenue in terms of share. It would occur due to the increasing manufacturing and usage of sensors, chips, and other microfluidic devices to offer novel and robust devices to the consumers. However, diagnostic centers and research institutes will also grow rapidly during the forecast period by utilizing microfluidic devices for various applications

The increasing awareness about healthcare importance of proper infrastructure in healthcare set-ups are boosting the global point-of-care diagnostics market, predicts Fortune Business Insights in their new report. The report is titled,” Point-of-care Diagnostics (POC)Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2026”.

According to the report, the market is anticipated to reach US$ 28,379.6 Mn by the end of 2026 from US$ 17,019.5 Mn in 2018. The forecast period is set from 2018 to 2026 and the market is expected to grow at a CAGR of 6.6%.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/point-of-care-diagnostics-market-101072

Key players leading the global Point of Care Diagnostics Market include

• Abbott
• Hoffmann-La Roche
• Johnson & Johnson
• BD
• Quidel
• Sekisui Diagnostics, LLC
• Danaher Corporation
• Siemens
• AccuBioTech Co., Ltd.
• Chembio Diagnostic Systems, Inc.
• EKF Diagnostics Holdings plc
• Instrumentation Laboratory (A Werfen Company)
• Nova Biomedical
• PTS Diagnostics

Get Sample PDF:

https://www.fortunebusinessinsights.com/industry-reports/point-of-care-diagnostics-market-101072

 “Increasing Need for Immunotherapy and Other Therapeutic Methods to Promote Growth”

The rise in geriatric population and their vulnerability towards various diseases is a major factor augmenting growth in the global point-of-care diagnostic market. This, coupled with the rising prevalence of infectious diseases is boosting the market. The rise in disposable incomes of people worldwide have encouraged people to opt for better healthcare treatment and facilities. This is further prognosticated to fuel the demand for point-of-care diagnostics market in the coming years.

Furthermore, prevailing occurrences of target diseases is propelling demand for point-of-care treatment methods such as molecular target therapy, immunotherapy, and other therapy methods. Such factors are anticipated to help the market generate better revenues in the years to come.

However, factors such as high cost of installation and high maintenance costs may hamper the market in the long run. Nevertheless, with advancement in technology and new product launches, the market is anticipated to grow remarkably in the years to come.

The global medical lasers market will witness considerable growth due to growing applications of medical lasers in surgical procedures. According to a report published by Fortune Business Insights, titled “Medical Lasers: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 3,778.9 Mn in 2018. Fortune Business Insights has predicted that the market will reach US$ 12,327.8 Mn by 2026, thereby exhibiting a CAGR of 15.9%.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/medical-lasers-market-101071

Some of the leading companies that are operating in the global market are

• En. S.p.A.,
• Lumenis,
• Fotona,
• Ellex Medical Lasers Ltd.,
• BIOLASE, Inc.,
• Sisram Medical Ltd.,
• IRIDEX Corporation,
• CANDELA CORPORATION,
• Topcon Corporation.

The ability of medical lasers to treat damaged or targeted tissues, through a minimally invasive procedure, has led to a huge demand across the world. Medical lasers possess the ability to diagnose and treat several diseases, which in turn will lead to a rising adoption across the world. The use of laser radiation comes with certain challenges; recent scientific advancements will favor the growth of the global medical lasers market in the forthcoming years. Resulting from the high demand, there have been numerous technological advancements in the manufacture of these equipment and this, according to Fortune Business Insights will constitute an increase in the global medical lasers market value in the forthcoming years. Growing applications of medical lasers have led to numerous clinical trials, which in turn has aided the growth of the global medical lasers market in recent years. The report focuses on several factors that have accounted for the growth of the global medical lasers market in the coming years.

Request a Sample Copy of the Global Medical Lasers Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/medical-lasers-market-101071

Increasing Product Launches Will Prove Chief Growth Driver

The rising adoption of medical lasers across diverse applications has encouraged companies to come adopt standout business strategies. Due to the presence of several medical lasers market companies, it is becoming difficult to establish a strong presence without product differentiation and this has sparked several product innovations. The report highlights a few of the noteworthy medical lasers market products that have contributed significant growth of the market in recent years. In May 2018, OmniGuide Surgical announced the launch of a new medical laser system, aimed at initiating enhanced surgical procedures. The company announced the commercial release of its C-LAS line of the Sight CO₂ laser system. Fortune Business Insights predicts that this product will help OmniGuide generate a substantial medical lasers market revenue. Additionally, Fortune Business Insights states that OmniGuide’s latest product will have a positive impact on the growth of the global medical lasers market in the forthcoming years.